Category: Immunodeficiency: primary or acquired

W.57 - Biological Efficacy and Safety of Intranasal Gnrh-analogue in Treatment-naïve hiv1 Infected Male Patients: An Open Phase Iia, Proof of Concept Trial

Wednesday, Jun 14
6:15 PM – 7:45 PM

Hans Friedemann Kinkel

University of Pretoria
Pretoria, Not Applicable, South Africa

Ola Winqvist

Karolinska Institutet
Stockholm, Stockholms Lan, Sweden